HIV and COVID-19: Pharmacists and Healthcare Systems Mitigate Risks

Approximately 1.1 million people in the U.S. are living with HIV today. In the midst of the global COVID-19 pandemic, a lack of information exists about whether HIV patients are at an increased risk for contracting the virus.

“So far, there is no major report to suggest that HIV patients are more or less susceptible to COVID-19 than individuals who do not have HIV or are otherwise healthy,” Rodney Ho, PhD, professor of pharmaceutics at the University of Washington School of Pharmacy in Seattle, told Drug Topics®. “We don’t know why.”

A new article on Drug Topics® discusses ways in which pharmacists and health care systems are adjusting to mitigate risk.

Read the full article on DrugTopics.com.